BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pacheco MB, Camilo V, Lopes N, Moreira-Silva F, Correia MP, Henrique R, Jerónimo C. Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines. Pharmaceuticals (Basel) 2021;14:670. [PMID: 34358096 DOI: 10.3390/ph14070670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wawruszak A, Borkiewicz L, Okon E, Kukula-Koch W, Afshan S, Halasa M. Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers (Basel) 2021;13:4700. [PMID: 34572928 DOI: 10.3390/cancers13184700] [Reference Citation Analysis]
2 Moreira-Silva F, Henrique R, Jerónimo C. From Therapy Resistance to Targeted Therapies in Prostate Cancer. Front Oncol 2022;12:877379. [PMID: 35686097 DOI: 10.3389/fonc.2022.877379] [Reference Citation Analysis]
3 Rocha SM, Sousa I, Gomes IM, Arinto P, Costa-Pinheiro P, Coutinho E, Santos CR, Jerónimo C, Lemos MC, Passarinha LA, Socorro S, Maia CJ. Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis. Life (Basel) 2021;11:1251. [PMID: 34833128 DOI: 10.3390/life11111251] [Reference Citation Analysis]